NewsHK
Registration filings in life sciences capital markets tend to surface long after the agreement that triggered them.
Twist Bioscience Corporation (Nasdaq: TWST) reached that point on August 19, 2026, filing an 8-K to cover a prospectus supplement registering the resale of shares issuable to Invenra Inc.
under a Stock Purchase Agreement signed six months earlier. The paperwork completes a transaction rather than announcing one. Both instruments cited in the current report carry the same date: February 11, 2026.
That is when Twist Bioscience and Invenra Inc. executed the Stock Purchase Agreement and, separately, the Registration Rights Agreement that now obliges this filing.
Keep reading